Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia

Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia–Related Epistaxis and Gastrointestinal Bleeding

(2018) Vivek N. Iyer et al.   MAYO CLINIC PROCEEDINGS

Selective effects of oral antiangiogenic tyrosine kinase inhibitors on an animal model of hereditary hemorrhagic telangiectasia

(2017) Y. H. Kim et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia

(2016) Kevin J. Whitehead et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of Bevacizumab Nasal Spray on Epistaxis Duration in Hereditary Hemorrhagic Telangectasia

(2016) Sophie Dupuis-Girod et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Dose – response relationship of bevacizumab in hereditary hemorrhagic telangiectasia

(2015) Nicolas Azzopardi et al.   mAbs

VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2

(2014) Chul Han et al.   ANGIOGENESIS

Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: A double-blind, randomized, placebo-controlled trial

(2014) Dominik Riss et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease

(2014) S. Gaillard et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study

(2014) Urban W. Geisthoff et al.   THROMBOSIS RESEARCH

Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu)

(2014) John E. Hanks et al.   International Forum of Allergy & Rhinology

The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia

(2014) Christian A. Merlo et al.   International Forum of Allergy & Rhinology

The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study

(2013) J W Donaldson et al.   THORAX

Management of Antiangiogenic Therapy-Induced Hypertension

(2012) Nilka de Jesus-Gonzalez et al.   HYPERTENSION

Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output

(2012) Sophie Dupuis-Girod et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Bevacizumab Attenuates VEGF-Induced Angiogenesis and Vascular Malformations in the Adult Mouse Brain

(2012) Espen J. Walker et al.   STROKE

Arteriovenous malformation in the adult mouse brain resembling the human disease

(2010) Espen J. Walker et al.   ANNALS OF NEUROLOGY

An epistaxis severity score for hereditary hemorrhagic telangiectasia

(2010) Jeffrey B. Hoag et al.   LARYNGOSCOPE

Suppression and Regression of Choroidal Neovascularization by the Multitargeted Kinase Inhibitor Pazopanib

(2009) Kyoichi Takahashi   ARCHIVES OF OPHTHALMOLOGY